Table 1

                                               Table.  Drugs for Brain Cancer

 

 

Product

 

Class

 

Target

 

Clinical Stage

 

Manufacturer

 

Lucanthone

 

Topoisomerase

 

Topoisomerase II

 

Phase II

 

SuperGen

 

RSR13

(Efaproxiral)

 

Small molecule

 

Sensitize hypoxic area of tumors

Phase III

(Brain metastases from breast cancer)

 

Allos